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Sydney, Australia; and Sendai, Japan
The human arterial system in youth is beautifully designed for its role of receiving spurts of blood from the left
ventricle and distributing this as steady flow through peripheral capillaries. Central to such design is “tuning” of
the heart to arterial tree; this minimizes aortic pressure fluctuations and confines flow pulsations to the larger
arteries. With aging, repetitive pulsations (some 30 million/year) cause fatigue and fracture of elastin lamellae
of central arteries, causing them to stiffen (and dilate), so that reflections return earlier to the heart; in conse-
quence, aortic systolic pressure rises, diastolic pressure falls, and pulsations of flow extend further into smaller
vessels of vasodilated organs (notably the brain and kidney). Stiffening leads to increased left ventricular (LV)
load with hypertrophy, decreased capacity for myocardial perfusion, and increased stresses on small arterial ves-
sels, particularly of brain and kidney. Clinical manifestations are a result of diastolic LV dysfunction with dys-
pnea, predisposition to angina, and heart failure, and small vessel degeneration in brain and kidney with intel-
lectual deterioration and renal failure. While aortic stiffening is the principal cause of cardiovascular disease
with age in persons who escape atherosclerotic complications, it is not a specific target for therapy. The princi-
pal target is the smooth muscle in distributing arteries, whose relaxation has little effect on peripheral resis-
tance but causes substantial reduction in the magnitude of wave reflection. Such relaxation is achieved through
regular exercise and with the vasodilating drugs that are used in modern treatment of hypertension and cardiac
failure. (J Am Coll Cardiol 2007;50:1–13) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.12.050“
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oilliam Osler’s axiom that “man is as old as his arteries”
eferred to arterial stiffening, with only 1 form of this
nodular arteriosclerosis, now called atherosclerosis) causing
rterial narrowing or obstruction (1). Contemporaries had
imilar views (2), and saw heart failure with aging as a
onsequence of progressive large arterial stiffening. At this
ime, no cuff sphygmomanometer was available, and mon-
toring was undertaken (if at all) with radial pulse wave
phygmograms (2–4).
This review revisits the original basic physiological con-
epts applied by pioneers, shows how they have been
mproved by new techniques, and can now be applied to
nderstand, monitor, and treat the aging process and its
equelae (4,5). The review complements the reviews whose
mphasis was on molecular, genetic, and biochemical mech-
nisms (5,6). Such approach enables better understanding of
ardiac and renal failure, and of vascular dementia, and of
ow these conditions may be prevented, delayed, or treated.
While we can separate atherosclerosis as a separate
isease from arteriosclerosis of aging, we cannot separate
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006, accepted December 10, 2006.hypertension” by which name most of the aging changes
re usually discussed (3,5). But blood pressure is a biomarker
f arteriosclerosis (7). Hypertension is a condition arbitrarily
efined by blood pressure limits that are achieved by the vast
ajority of the population who reach 90 years of age (8),
nd is better described by underlying structural change.
owever, separation of disease from aging becomes arbi-
rary in the elderly. It is man’s destiny to die (colloquially
rom “natural causes”), and rarely over age 100 years.
hough specific causes are written on a death certificate,
hese are usually an inevitable consequence of the aging
rocess and include cardiac and renal failure, cardiac and
erebral ischemia.
ormal Arterial Function: Basic Physiology
he arterial tree has 2 functions—first, to deliver blood
rom the left ventricle (LV) to capillaries of bodily organs
nd tissues according to their need, and second, to cushion
he pulsations generated by the heart so that capillary blood
ow is continuous or almost so. The first function is that of
conduit, the second of a cushion (4,5).
The arterial system is a very effective conduit and a very
fficient cushion. Integration of functions leads to pressure
ave travel and reflection (4) (Fig. 1). Wave reflection
ccurs predominantly at the origin of the myriad of termi-
ations of low resistance arteries into high-resistance arte-
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Mechanical Factors in Arterial Aging July 3, 2007:1–13rioles. Despite physical disper-
sion of such sites at different
distances from the heart, and
consequent interaction of re-
flected waves, one can usually
discern a functionally discrete re-
flected wave in the arterial pulse
(Fig. 1). While the ejection
(flow) wave from the heart has a
single impulse, the pressure wave
has 2 impulses (4) (Fig. 1). The
beginning of the reflected wave
in the ascending aorta in youth
corresponds (during exercise if
not at rest) to the incisura or
high-frequency notch created by
aortic valve closure (4).
Correspondence of a vascular event (return of the re-
ected wave) to a cardiac event (aortic valve closure with
eginning of diastole) bespeaks another aspect of cardiovas-
ular efficiency. Pressure is increased during diastole only,
hen the myocardial microvasculature can be perfused. The
esign of the arterial tree with conduit and cushion func-
ions combined exploits wave reflection to enhance coronary
ow (4,9). The heart and vascular tree are, thus, normally
tuned” for optimal efficiency. This is further illustrated in
he frequency domain where the minimal value of imped-
nce modulus (pulsatile pressure  pulsatile flow) in the
Figure 1 Distributed Models of the Arterial Tree
Simple tubular models of the arterial system, connecting the heart (left) to
the peripheral circulation (right) in a young (top) and old (bottom) subject. In
the young subject, the tube is distensible, whereas in the old subject it is stiff.
The distal end of the tube constitutes a reflection site where the pressure
wave travelling down the tube is reflected back to the heart. The wave travels
slowly in the young distensible tube so that the reflected wave boosts pressure
in diastole when it returns to the proximal end. The wave travels faster in the
old stiffer tube, returns earlier, and boosts pressure in late systole. Flow input
from the heart is intermittent in both young and old subjects. In the young sub-
ject, pulsations are absorbed in the distensible tube so that outflow is steady
or almost so. In the old subject with stiff tube, pulsations cannot be absorbed,
and so output from tube into peripheral microvessels is pulsatile.
Abbreviations
and Acronyms
ACEI  angiotensin-
converting enzyme inhibitor
AIx  augmentation index
ARB  angiotensin
receptor blocker
CCB  calcium-channel
blocker
C-F  carotid-femoral
LV  left
ventricle/ventricular
LVH  left ventricular
hypertrophy
PWV  pulse wave velocityhscending aorta is seen to correspond to the maximal values
f the LV ejection (flow) wave (4,9).
Factors determining optimal efficiency of vascular/
entricular interaction include greater distensibility of the
roximal than distal aorta, dispersion of peripheral reflecting
ites, the location of the heart in the upper thorax, and the
nverse relationship between heart rate and body length
4,10). Such efficiency in man, however, is fragile. As the
orta ages and stiffens, aortic pulse wave velocity (PWV)
ncreases, wave reflection returns earlier, and favorable
tuning” between LV and arterial tree is progressively lost
4,11) (Fig. 1). It is, however, maintained from the time full
ody length is achieved (about 17 years) through the time of
eak procreative capacity (about 30 years) and must have
een a survival advantage for humans from an evolutionary
iewpoint. Arterial aging is the story of what happens
eyond age 30 years!
ow Does Aging Affect Arterial Properties?
any studies of aging focus on factors that affect the intima,
ather than the load-bearing media. Studies on intima-
edia thickness show progressive thickening with age (12).
utopsy studies of perfusion-fixed human arteries have
hown that thickening is mostly confined to the nonload-
earing intima, and is principally due to intimal hyperplasia
13). While the media may not appreciably thicken with
ge, individual elastin lamellae actually thin and become
eparated by increasing amounts of nonload-bearing mate-
ial (14) (Fig. 2).
Elastic arteries show 2 major physical changes with age
4,5). They dilate, and they stiffen (Figs. 2 and 3). Changes
re most marked in the aorta, and its major proximal
ranches are less marked in the peripheral muscular arteries
4,15–20). The proximal elastic arteries and aorta dilate by
pproximately 10% with each beat of the heart in youth,
hile the muscular arteries dilate by only 2% to 3% with
ach beat (21) (Fig. 4). Such difference in degree of stretch
an explain differences in aging change between proximal
nd distal arteries, on the basis of material fatigue (4,22).
here is no reason to believe that principles of fatigue and
racture do not apply to the nonliving material in the body
23), especially elastin, which is the most inert substance in
he body and has a half-life of decades (4). For 10%
xtension of natural rubber (24), fracture is calculated to
ccur at 8  108 cycles (corresponding to 30 years at heart
ate of 70 beats/min). Fracture of elastic lamellae is seen in
he aorta with aging (13) (Fig. 2), and can account both for
ilation (after fracture of load-bearing material) and for
tiffening (through transfer of stresses to the more rigid
ollagenous components of the arterial wall). For peripheral
rteries with 3% extension, and the same number of cycles,
racture is not expected to occur till over 3  109 cycles,
hich corresponds to well over 100 years of life. While
istological studies show gross damage to the medial elastin
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July 3, 2007:1–13 Mechanical Factors in Arterial Agingf the proximal aorta they show little change in distal
uscular arteries (4,13,21).
These physical engineering principles extend the classic
iews, account for the difference between central and pe-
ipheral arteries, and the increased stiffening and dilation of
roximal arteries, and explain the histological changes.
ow Does Aging Affect Arterial Function?
athophysiology. Since aging causes arterial dilation, and
f proximal elastic arteries, it does not affect conduit
unction of the arterial tree. But it has a marked and
rogressive effect on cushioning function (4,5) and ulti-
ately a devastating effect on the heart, and the microcir-
ulation, especially in brain and kidney. Increased arterial
tiffening with age is apparent as increase in PWV (4,15,16)
Fig. 3). This is greatest in the aorta, and least in muscular
rteries such as those of the upper limb.
“Aortic” PWV is estimated noninvasively from the delay
Figure 2 Cartoon of Young and Old Human Aorta
Schematic diagram of the aorta section in a young (left) and old (right)
human, with inset (below each) the components of the aortic wall. The wall of
the older human is disorganized as a consequence of fraying and fracture of
the elastic lamellae (yellow) and loss of muscle attachments (red), together
with increase in collagen fibers (black) and mucoid material (green), and with
foci of “medionecrosis.” Drawn by O’Rourke CM, after Glagov S. Personal com-
munication, 1994.f pressure wave foot at the femoral site compared to thearotid site, and from the distance traveled by the pulse. A
ypical value in a 20-year-old is 5 m/s and in an 80-year-old
s 12 m/s (i.e., a 2.4-fold increase over 60 years) (4,15,16).
imilar values have been determined for characteristic im-
edance (pulsatile pressure  pulsatile flow in the absence
f wave reflection) in the ascending and proximal aorta
25,26). These values imply a 4-fold increase in aortic
lastic modulus, since PWV depends on the square root of
lastic modulus (4).
Ascending aortic impedance at heart rate frequency
ncreases approximately 4-fold between 20 and 80 years (4)
Fig. 5). This is a consequence of early wave reflection
dding to increased characteristic impedance. Implications
re apparent from increase in aortic pulse pressure with age.
he approximately 2-fold increase in aortic PWV between
0 and 80 years is not apparent in brachial pulse pressure.
hile this increases with age (4,6), the extent of change is
idden since the brachial pulse in youth is markedly
mplified, whereas amplification is far less at 80 years of age
Fig. 4).
It is clear that effects of aging on arterial function have
een underestimated in the past, on account of reliance on
he brachial cuff systolic pressure. This increases with age
rom about 120 to 145 mm Hg (i.e., by around 20%
etween age 20 and 80 years) (4,27,28). With fall in
iastolic pressure from, say, 80 to 75 mm Hg, brachial pulse
ressure increases more — from some 35 to 60 mm Hg (i.e.,
y 70%) (6,28), while aortic pulse pressure increases far
ore—from some 22 to 65 mm Hg (i.e., by 200%) (4) (Fig.
). Reliance on cuff sphygmomanometric values results in
nderappreciation of aging change. So does the present
oncept of hypertension, dependent as it is entirely on
rachial cuff pressures (4,5).
Figure 3 Change in Aortic PWV With Age
Change in aortic pulse wave velocity (PWV) with age in a group of 480 normal
subjects in a northern urban Chinese community with low prevalence of athero-
sclerosis (15). The regression line for this group (top) was significantly differ-
ent from that of another normal Chinese community in Guandong (bottom)
with similarly low prevalence of atherosclerosis but low salt intake and lower
prevalence of hypertension (16).
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Mechanical Factors in Arterial Aging July 3, 2007:1–13ffect of Aging Process on the Heart
ortic stiffening with age leads to increase in pressure
hroughout systole (both from stiffening of the proximal
orta and early return of wave reflection), and to decrease in
ortic pressure throughout diastole (4–6). Increase in pres-
ure throughout systole increases LV load. Increased ven-
Figure 4 Changes With Age in Structural and Functional Prope
of the Human Proximal Aorta and Large Muscular Arte
(Left from top and down) Diameter of the ascending aorta (17), surface area of th
chial cuff pressure (27). (Right from top and down) pulsatile expansion (%) of the
(Asc. Ao. Zc) (25), and amplification of the pressure pulse between ascending aorricular load leads to LV hypertrophy (LVH), and to pncrease in LV oxygen requirements (29). All predispose to
evelopment of LV failure (8). The hypertrophied heart
ontracts (and relaxes) more slowly, so that duration of
ystole is increased and of diastole reduced at any given
eart rate (4,5). When duration of systole is lengthened,
ave reflection causes further augmentation of late systolic
From 20 to 80 Years
a (18), carotid intima-media (IM) thickness (12), and systolic and diastolic bra-
d artery and radial artery (21), ascending aortic characteristic impedance Zc
 radial artery ( solid line [19]); and femoral artery (dashed line [20]).rties
ries
e aort
 caroti
ta andressure; thus, tension-time index and myocardial oxygen
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July 3, 2007:1–13 Mechanical Factors in Arterial Agingeeds are boosted by increases in both tension and time
4–6) (Fig. 7).
These increased coronary blood flow requirements are,
owever, associated with decreased ability to supply such
lood on account of: 1) decreased aortic pressure throughout
iastole; and 2) reduced period of diastole as systolic
jection duration, and slowed relaxation, impinge on dura-
ion of the cardiac cycle (4–6,30). Impaired capacity for
oronary flow develops quite independently of coronary
arrowing, but is worsened by any degree of atherosclerosis
31) (Fig. 7).
The combination of increased blood need and de-
reased capacity for coronary perfusion predisposes to
schemia (31). Any degree of ischemia worsens the
ituation by causing further impairment of ventricular
elaxation and prolongation of ejection period (4 – 6)
Fig. 6) — all tending to decrease ventricular perfusion
hroughout diastole.
Figure 8 illustrates the mechanism that predisposes the
V to ischemia and to dysfunction from impaired relaxation
Figure 5 Aortic Impedance at Age 20 and 80 Years
Ascending aortic impedance shown schematically in a young 20-year-old and in
an 80-year-old human subject showing the effect of doubling of characteristic
impedance (older curve set higher) and early return of wave reflection (first min-
imum at double the frequency). In consequence of both, impedance modulus
at heart rate frequency is increased 4-fold (4).ith increasing age. mThis mechanism links LVH with ischemia and so, with
redisposition to angina even with what ordinarily might be
onsidered hemodynamically insignificant coronary stenosis
31) or with no coronary stenosis (4,30). A vicious cycle
ecomes relevant in the development of “diastolic” LV
ailure, probably the most common form of heart failure in
he elderly (32).
ffects of Age on the Microcirculation
he microcirculation is generally taken as comprising small
rteries 400 m, arterioles 100 m diameter, and the
apillaries beyond (4,5,33). These vessels usually present the
reatest resistance to blood flow, and complete the change
f pulsatile flow to steady flow in capillaries by repelling
reflecting) the pulsations that enter from the larger arteries.
he transition from pulsatile to steady flow is complete in
ost organs and tissues. However, in those with high
esting flow, notably the brain and kidneys, pulsations may
xtend more deeply towards the capillaries (4,5,33,34). In
he pulmonary circulation, resistance is normally so low and
rteriolar vessels so short that pulsations extend into the
apillaries, and even through into pulmonary veins (35).
In contrast to the large elastic arteries, studies of aging
ave not found specific structural changes in the microcir-
ulation of the skin and subcutaneous tissues (33,36).
unctional changes appear to be relatively minor and
omprise impaired endothelial-dependent, and endothelial-
ndependent vasodilation (33). Even these have often been
ttributed to coexistent hypertension. Changes in microcir-
ulation of the vital organs such as brain and kidney of older
ersons are marked, but there are usually, though not always
37), attributed to hypertension or intercurrent disease such
s diabetes, renal insufficiency, or congenital defects of
onnective tissue (38,39).
Studies of large arteries and their changes with age, as
escribed already, have inevitably led to the microcircula-
ion, as apparent from flow waves depicted in Figure 1. If
ow pulsations created by LV ejection cannot be cushioned
n the arterial system in older persons, then where are they
bsorbed? If pulsatile energy loss in the circulation is more
han doubled by stiffening of the aorta (40), what ill effects
ight this have, and where? If pulsations of the aortic wall
ver the first 30 years of life can induce elastin fiber fatigue
nd fracture (4) (Fig. 2), what might pulsation in the
icrocirculation do in the subsequent 50 years? The most
ulnerable circulations would be those in the brain and
idneys, since the blood vessels leading down to the capil-
ary circulation are more dilated than elsewhere and would
ransmit pulsations more readily into the smallest vessels
4,41,42) (Fig. 9). It is in the microcirculation of the brain
nd kidney that one sees the most severe lesions in older
ersons (39,43,44), and these are similar to the pulmonary
icrovascular lesions that develop over years in congenital
h
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Mechanical Factors in Arterial Aging July 3, 2007:1–13eart disease with left-right shunt causing high pulmonary
ow pulsations, even in the absence (initially) of pulmonary
ypertension (45). The lesions include damage to endothe-
ium with thrombosis, and to the media with edema,
emorrhage, and inflammation (39,43,44) (i.e., features of
edionecrosis caused by physical damage) (46,47).
This is a new evolving area that links neurology, nephrol-
gy, cardiology, and geriatrics with magnetic resonance
Figure 6 Pressure Waveforms in Arm and Aorta of Young, Midd
Pressure waveforms measured in the radial artery (top) and synthesized for the as
48-year-old at center, and a 97-year-old at right. Pulse pressure is increased almo
0.5 s.
Figure 7 Aortic and LV Pressure Waves in Young and Old Subje
Ascending aortic and left ventricular (LV) pressure waves shown schematically in a
tion at right. In the older person, myocardial oxygen demands (vertically hatched
increased duration of systole. Ability for myocardial oxygen supply is reduced by sh
pressure during diastole caused by LV dysfunction.maging and other imaging techniques (42,48–50). A full
iscussion is not possible here, but links between large artery
tiffening and microvascular disease in brain and kidney, and
amage to and dysfunction of these organs (42,51–53), are
onsistent with the strong and causative association that had
een described (41,42) on the basis of pathophysiological
echanisms. Carotid flow pulsation increases with age, in
ssociation with arterial stiffening and greater pressure wave
ed, and Old Subjects
ng aorta (bottom) in 3 women of the same family—an 18-year-old at left, a
ld in the ascending aorta and 2-fold in the upper limb (4). Time calibration 
subject at left and older subject with LV hypertrophy and diastolic LV dysfunc-
are increased by the increase in LV and aortic systolic pressure and by the
duration of diastole, lower aortic pressure during diastole, and increased LVle-Ag
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July 3, 2007:1–13 Mechanical Factors in Arterial Agingugmentation (54) (Fig. 10). Superior sagittal sinus flow
ulsations also increase with age and are most prominent in
atients with “pulse wave encephalopathy” and dementia
48,50). From a therapeutic and monitoring viewpoint,
nterventions that reduce arterial stiffness, early wave reflec-
ion, or aortic pressure fluctuations are likely to improve the
mall as well as large arteries of vital organs and thereby
elay, prevent, or improve cerebral and renal dysfunction in
he elderly (54–58).
Figure 8 Ill Effects of Aging
LV  left ventricular.
Figure 9 Pulsatile Pressure Changes in the Vascular Tree
Schematic representation of pulsatile pressure change between left ventricle and
human with arterial stiffening (right). In the older person, pulsations are not absoonitoring of Aging Change
variety of methods have been proposed for determination
f aging change, and to supplement routine measurement of
uff systolic and pulse pressure (4–7). The simplest is the
nger photoplethysmograph, whose pulsatile volume
hange is similar to the carotid pressure waveform (59) and
hose change with age can be described as augmentation or
n terms of derivatives (60). The most sophisticated involve
ries of a young subject (left) and an older
the large arteries and so extend down into the microcirculation.capilla
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Mechanical Factors in Arterial Aging July 3, 2007:1–13easurement of aortic or carotid diameter with a phase
ocked echo tracking device (61), central pulse pressure by
ifferent means (4,5,62), and aortic flow by ultrasound
63,64); from these central measures, aging change can be
escribed in terms of elastic modulus or aortic impedance.
ll methods depend on measurement of pulsatile phenom-
na and, directly or indirectly, arterial stiffness. All are
escribed in recent books and reviews (4,5,62). All have
dvantages and disadvantages. The 2 most popular consid-
red in guidelines (65), and recommended by a European
onsensus group for clinical and epidemiological studies
62), are determination of carotid-femoral (C-F) PWV and
ulse waveform analysis.
-F PWV. Carotid-femoral PWV can be measured simply
nd quickly, and with good reproducibility (4–6,62). This
easure is incorporated in Framingham and National In-
titute of Aging studies (7). Diseases such as diabetes
ellitus and end-stage renal failure are characterized by
igh C-F PWV; in a recent study (66), a difference of 1.6
/s in diabetics can reasonably be interpreted as equivalent
o greater functional arterial age of approximately 15 years
4). Carotid-femoral PWV as a measure of aortic stiffness is
ssociated with cardiovascular events, independently of con-
entional risk factors, in patients with hypertension, end-
tage renal failure, diabetes, the elderly, and in normal
opulations (62,66–73).
ulse waveform analysis: radial and carotid pressure
onometry. Over a century ago, clinicians described aging
hange as progressive rise in the late systolic component of
he radial artery pulse (2–5). This was also applied in life
Figure 10 Relationship Between Augmentation of
Flow and Pressure Waves in the Carotid Artery
Relationship between augmentation of simultaneously recorded flow (ordinate)
and pressure (abscissa) waves in the carotid artery of 56 normal subjects age
20 to 72 years (R  0.913, p  0.0001). Lowest values of augmentation were
seen in younger and highest values in older individuals. Inset is method used
for calculating flow and pressure augmentation as late systolic augmentation 
pulse height (54).nsurance examinations to exclude applicants with prema- iure arterial senility (3). The modern approach (4,11,62)
ses high-fidelity tonometers to record noninvasively details
f the radial and/or carotid pressure waveforms and math-
matical processing to identify features of the wave, includ-
ng the late systolic augmentation described by pioneers.
ne (SphygmoCor, AtCor Medical, West Ryde, Australia)
oes further to generate the aortic from the radial pressure
ulse using a generalized transfer function to correct distor-
ion in the upper limb (4,5,61,62); the Food and Drug
dministration has accepted this as substantially equivalent
o aortic pressure measured by catheterization.
Radial, carotid, or aortic pressure waveforms can be com-
ared against normal pressure waves at different ages (11) or
he most prominent aging feature, the augmentation index
AIx) (74,75) (Fig. 11), can be compared against normal data
t different ages. The AIx increases progressively with age in all
rteries, up to age 60 whereafter it flattens off (74,75). At any
ge, AIx is higher in women than men. Arterial age may be
stimated in an apparently healthy subject from comparison of
n individual’s AIx against normal data, at least up to 60 years
f age. Precision may be improved by applying a correction for
eart rate (4,5,74). Augmentation of pressure in the carotid
rtery is closely associated with augmentation of flow; this is an
llustration of the link between large artery stiffness and
ncreased cerebral flow pulsations with age (54) (Fig. 10). Pulse
aveform analysis permits measurement of central (aortic or
arotid) systolic and pulse pressure as well as duration of systole
nd diastole. Diastolic period is characteristically reduced in
lder persons, especially those who develop “diastolic” heart
ailure (32).
Carotid AIx is independently associated with cardiovas-
ular outcomes in patients with end-stage renal failure (76)
nd coronary disease (77). The flattening of AIx with age
ver 60 years (Fig. 11) and in diabetic patients over 45 years
66) has been attributed to change in the LV ejection (flow)
ave (4), in consequence of impaired contractility (4,78)
nd contrasts with progressive increase in C-F PWV
Fig. 3). The dissociation between PWV and AIx is seen
nder age 60 in diabetic patients (66) and may be a sign of
remature impairment of LV contractility in the face of
ncreased aortic stiffness (4,70,78).
Potential value of waveform analysis for individual assess-
ent can be seen when a 68-year-old individual and his
7-year-old son are compared at identical brachial cuff pres-
ures (Fig. 12). The older man’s AIx was consistent with his
ge while the younger man’s was even more youthful than
xpected for age but consistent with his regular exercise habit.
hile systolic peak pressure was similar, aortic systolic pressure
n the younger man was 17 mm Hg less than his father.
revention, Treatment
n this review, we approach aging as a mechanical “wear and
ear” issue that affects nonliving components of the body, as
t likewise affects the components and fate of an old tree.
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July 3, 2007:1–13 Mechanical Factors in Arterial Aginghe sperm of the old man and the acorn of the tree can
ecreate the cycle of life, but man and the tree are doomed
y the structure in which the cells exist. While we cannot be
s optimistic as those who look to a genetic, molecular, or
hemical solution, we can suggest how principles described
ere can be applied to slow the process of arterial aging and
ffset its inevitable ill effects and the diseases, such as
therosclerosis, which it promotes.
The key to prevention and treatment is to minimize
rterial pulsations, since these are the basic cause of large
rtery degeneration from elastin fiber fatigue and fracture,
hen of microvascular damage as pulsations are funneled
nto smaller vessels. Yet the heart has to beat, and so the
rteries to throb, as long as the body lives. Possible targets for
herapy are the proximal elastic and distal muscular arteries.
entral arteries. Attention has been directed at the struc-
ural matrix proteins, collagen and elastin in the arterial
all, and the advanced glycation end products (AGE) that
ccumulate on the proteins, alter their physical properties,
nd cause the fibers to stiffen. Drugs such as ALT711
alagebrium) can break established AGE cross-links be-
ween proteins, and can decrease arterial stiffening in
xperimental animals (79). While studies on animals, in-
luding aged primates, have been encouraging, results to
ate in humans have been less so with little or no change in
ortic stiffness (80,81). When one considers the gross
Figure 11 Relationship Between Age and Ascending Aortic Pre
Relationship between age and ascending aortic pressure wave augmentation (A) c
cardiovascular outpatient clinic, together with values for a group of 4,001 normal 
534 normal European subjects (men and women combined, thick line) from Wojci
tation. AIx  augmentation index; PP  pulse pressure.amage to the elastin fibers in the aorta in older human iubjects with disruption of muscular attachments (Fig. 2), it
s hard to envisage benefit from any drug at this site. It is
ntirely possible, however, that the drug does have beneficial
ffects on lesser degrees of damage in more peripheral
uman arteries or in central arteries of (relatively) younger
nimals. There may be a place for this drug at an earlier
tage of human aging.
There is some evidence that angiotensin-converting enzyme
nhibitor (ACEI) drugs may delay progression of aortic stiff-
ning in patients with renal failure (82) and angiotensin
eceptor blockers (ARBs), aortic dilation in Marfan syndrome
83). In some patients with renal failure on dialysis, an ACEI
as able to prevent progressive increase in aortic PWV, and
hese patients had fewer subsequent events than those who did
ot respond to the drug (82).
In trials of antihypertensive agents, aortic PWV de-
reased passively in line with reduction in arterial pressure,
nd to a similar degree with different drugs (84,85).
uscular conduit arteries. In contrast to central elastic
rteries, there is strong evidence that arterial vasodilator
rugs and exercise can markedly reduce wave reflection, and
hereby decrease the augmentation of both the central
ressure pulse, which in older humans impairs cardiac
unction, and of the augmented flow pulse, which damages
he microcirculation. Studies of nitrates at cardiac catheter-
zation have shown marked reduction in wave reflection and
Wave Augmentation
ed with SphygmoCor from radial artery tracings in 1,600 patients attending a
en (red thin line) and women (red dashed line) from McEniery et al. (74) and
ska et al. (75). (Inset, upper left) Method of calculating aortic pressure augmen-ssure
alculat
U.K. m
echown aortic and LV systolic pressure with no significant change
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Mechanical Factors in Arterial Aging July 3, 2007:1–13n aortic stiffness (measured as characteristic impedance or
WV) (4,86), and no or far less change in peripheral systolic
ressure (87,88). Such beneficial effects were also seen at
ardiac catheterization with an ACEI (89) and calcium-
hannel blockers (CCBs) (90) as well as with nitrates, and in
hronic studies (where effect was determined by carotid or
adial tonometry), with ACEIs, CCBs, and vasodilating
eta-blockers (91,92), but not atenolol (Fig. 13). Reduction
n wave reflection and central systolic pressure explained
enefits of ACEIs, ARBs, and CCBs over atenolol and
lacebo with respect to cardiovascular events in major trials
uch as HOPE (the Heart Outcomes Prevention Evaluation
tudy), LIFE (Losartan Intervention For Endpoint reduc-
ion in hypertension study), and ASCOT (Anglo-
candinavian Cardiac Outcomes Trial) (4) and led on to the
EASON (Improvement in blood pressure, arterial stiffness
nd wave reflections with a very-low-dose perindopril/
ndapamide combination in hypertensive patient: a compar-
son with atenolol) (84) and CAFÉ (Conduit Artery Func-
ion Evaluation) (85) studies. The REASON and CAFÉ
tudies showed that, in older hypertensive patients, wave
eflection could be reduced substantially by an ACE or
CB, and that this could decrease central aortic systolic
ressure and could account for reduction in cardiovascular
vents and in LV mass. The same explanation can be offered
Figure 12 Arm and Aortic Pressure Waves in Young and Old Su
Radial (left) and aortic (right) pressure waves in a 36-year-old man (top) and his
diastolic pressure. For the same brachial systolic value, difference in waveform wa
for recording radial wave, SphygmoCor for analysis.o explain benefits of ACEI, ARB, and CCB therapy in fecreasing cerebral and renal deterioration, which is attrib-
table to microvascular damage (54–58).
The mechanism whereby arterial vasodilators—ACEIs,
RBs, CCBs, and nitrates reduce wave reflection—was
tudied by Yaginuma et al. (86) and Bank et al. (93) with
itrates. The arterial smooth muscle acts as though in
arallel with elastin components of the wall but in series
ith collagen, such that with muscle relaxation, stresses are
ransferred to elastin so that the dilated artery is less rather
han more stiff (4). The combination of dilation and
ecreased stiffness of the conduit vessels causes reduction in
ave reflection (86). It is possible that newer drugs will be
ound that are more effective in conduit artery dilation and that
an have a greater beneficial effect on reducing wave reflection
nd, so, the ill effects of arterial aging in the circulation.
Multiple studies attest to the benefits of physical exercise,
nd to the improvement in oxygen extraction from blood
nd in cardiovascular function that occurs with exercise
raining (94,95). While exercise training does not show any
onsistent improvement in stiffness of large elastic arteries
96,97), exercise is associated with improvement in endo-
helial function of muscular arteries (94) with reduction in
ave reflection from peripheral sites (98,99). Such benefits
ome on after several weeks and persist for 1 month or more
fter discontinuation. Persons who exercise usually refrain
s
r-old father (bottom) calibrated to the same brachial cuff values of systolic and
onsible for a 17-mm Hg lesser value of aortic pressure. Millar tonometer usedbject
68-yea
s resprom other adverse lifestyle habits—smoking, coffee drink-
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July 3, 2007:1–13 Mechanical Factors in Arterial Agingng—that increase wave reflection (100). Healthy habits, in-
luding exercise, become more important as age advances.
Regular exercise leads to reduction of arterial pressure and
eart rate (95) and, hence, to both the extent of arterial
train at each cycle and the number of cycles. There is logic
or using a beta-blocker to reduce elevated heart rate in a
erson with hypertension already receiving an effective dose
f ACEI, ARB, or CCB to reduce wave reflection. Beta-
locker therapy can slow progressive dilation of the ascend-
ng aorta in Marfan syndrome (101). However, potential ill
ffects of beta-blockers as monotherapy for hypertension are
ecoming increasingly apparent (102).
As presented in this review, arterial aging is progressive
rom adolescence and causes problems at an accelerating
ace as age advances. At what stage is drug intervention
arranted? To date, we have depended on the sphygmoma-
ometric figure of 140 mm Hg for systolic pressure before
nitiating drug therapy. A lower figure of 130 mm Hg is
uggested by Julius et al. (103), and is already implemented
n patients with diabetes mellitus or renal insufficiency (4,5).
t makes more sense to consider central systolic pressure and
value of perhaps 120 to 125 mm Hg. Future trials will
etermine this. In the interim the old advice stands.
xercise regularly; watch the calories, the coffee, and the
alt. No cigarettes. Enjoy yourself, and take advantage of
Figure 13 Arm and Aortic Pressure Waves in Old Subject Befor
Radial (left) and aortic (right) pressure waves in a 68-year-old man under control
greater (8 mm Hg) reduction of aortic than brachial systolic pressure. ACEI  angi
 pulse pressure; SP  systolic pressure.our heart’s beat before it wears you out!eprint requests and correspondence: Dr. Michael F. O’Rourke,
uite 810, St. Vincent’s Clinic, 438 Victoria Street, Darlinghurst,
SW 2010, Australia. E-mail: m.orourke@unsw.edu.au.
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